Risk factors and evolution of weight loss in Parkinson's disease: A 9-year population-based study.

Autor: Kristiansen I; Center for Movement Disorders, Stavanger University Hospital, Stavanger, Norway; Department of Physical Medicine and Rehabilitation, Stavanger University Hospital, Stavanger, Norway; Faculty of Health Sciences, University of Stavanger, Stavanger, Norway; Research Group of Nursing and Health Sciences, Research Department, Stavanger University Hospital, Stavanger, Norway. Electronic address: Ida.Kristiansen@sus.no., Hiorth YH; Center for Movement Disorders, Stavanger University Hospital, Stavanger, Norway; Department of Physical Medicine and Rehabilitation, Stavanger University Hospital, Stavanger, Norway; Research Group of Nursing and Health Sciences, Research Department, Stavanger University Hospital, Stavanger, Norway. Electronic address: ylva.hivand.hiorth@sus.no., Ushakova A; Department of Research, Section of Biostatistics, Stavanger University Hospital, Stavanger, Norway. Electronic address: anastasia.ushakova@sus.no., Tysnes OB; Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Neurology, Haukeland University Hospital, Bergen, Norway. Electronic address: ole-bjorn.tysnes@helse-bergen.no., Alves G; Center for Movement Disorders, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Norway; Department of Neurology, Stavanger University Hospital, Stavanger, Norway. Electronic address: guido.alves@sus.no.

Publikováno v: Parkinsonism & related disorders [Parkinsonism Relat Disord] 2024 Dec; Vol. 129, pp. 107181. Date of Electronic Publication: 2024 Oct 22.

Substance Use Within Trials of Psychological Interventions for Psychosis: Sample Inclusion, Secondary Measures, and Intervention Effectiveness.

Autor: Halsall L; Division of Health Research, Spectrum Centre for Mental Health Research, Lancaster University, Lancaster, England., Ushakova A; Faculty of Health and Medicine, Centre for Health Informatics, Computing and Statistics, Lancaster University, Lancaster, England., Jones S; Division of Health Research, Spectrum Centre for Mental Health Research, Lancaster University, Lancaster, England., Chowdhury S; Faculty of Health and Medicine, Lancaster Medical School, Lancaster University, Lancaster, England., Goodwin L; Division of Health Research, Spectrum Centre for Mental Health Research, Lancaster University, Lancaster, England.

Publikováno v: Schizophrenia bulletin [Schizophr Bull] 2024 Nov 08; Vol. 50 (6), pp. 1489-1498.

Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson's Disease.

Autor: Pedersen CC; The Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway., Ushakova A; Section of Biostatistics, Department of Research, Stavanger University Hospital, Stavanger, Norway., Alves G; The Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.; Department of Neurology, Stavanger University Hospital, Stavanger, Norway., Tysnes OB; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Department of Neurology, Haukeland University Hospital, Bergen, Norway., Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Paris Brain Institute, ICM, Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France.; Neurodegenerative Disorder Research Center, Division of Life Sciences and Medicine, and Department of Neurology, Institute on Aging and Brain Disorders, University of Science and Technology of China and First Affiliated Hospital of USTC, Hefei, P.R. China., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA., Maple-Grødem J; The Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway., Lange J; The Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. johannes.lange@sus.no.; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway. johannes.lange@sus.no.

Publikováno v: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2024 Aug 21; Vol. 10 (1), pp. 162. Date of Electronic Publication: 2024 Aug 21.

Personality traits as predictors of recovery among patients with substance use disorder.

Autor: Fodstad EC; Department of Psychosocial Science, Faculty of Psychology, University of Bergen, Bergen, Norway; Centre for Alcohol and Drug Research (KORFOR), Stavanger University Hospital, Stavanger, Norway. Electronic address: ecgr@sus.no., Erga AH; Centre for Alcohol and Drug Research (KORFOR), Stavanger University Hospital, Stavanger, Norway; Department of Social Studies, Faculty of Social Sciences, University of Stavanger, Stavanger, Norway., Pallesen S; Department of Psychosocial Science, Faculty of Psychology, University of Bergen, Bergen, Norway., Ushakova A; Department of Research, Section of Biostatistics, Stavanger University Hospital, Stavanger, Norway., Erevik EK; Department of Psychosocial Science, Faculty of Psychology, University of Bergen, Bergen, Norway.

Publikováno v: Journal of substance use and addiction treatment [J Subst Use Addict Treat] 2024 Jul; Vol. 162, pp. 209360. Date of Electronic Publication: 2024 Apr 16.

Exercise training and high-sensitivity cardiac troponin-I in patients with heart failure with reduced ejection fraction.

Autor: Riveland E; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.; Institute of Clinical Science, University of Bergen, Stavanger, Norway., Valborgland T; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway., Ushakova A; Department of Research, Section of Biostatistics, Stavanger University Hospital, Stavanger, Norway., Skadberg Ø; Department of Biochemistry, Stavanger University Hospital, Stavanger, Norway., Karlsen T; Faculty of Nursing and Health Sciences, Nord University, Bodø, Norway.; Department of Circulation and Medical Imaging, Cardiac Exercise Research Group, Norwegian University of Science and Technology, Trondheim, Norway., Hole T; Department of Circulation and Medical Imaging, Cardiac Exercise Research Group, Norwegian University of Science and Technology, Trondheim, Norway.; Møre og Romsdal Health Trust, Ålesund Hospital, Ålesund, Norway.; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway., Støylen A; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway., Dalen H; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Medicine, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.; Clinict of Cardiology, St. Olavs University Hospital, Trondheim, Norway., Videm V; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olavs University Hospital, Trondheim, Norway., Koppen E; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Linke A; Technische Universität Dresden, Herzzentrum, Dresden, Germany., Delagardelle C; Hospital Centre of Luxembourg, Luxembourg, UK., Van Craenenbroeck EM; Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.; Research Group Cardiovascular Diseases, Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium., Beckers P; Department of Cardiology, Antwerp University Hospital, Edegem, Belgium.; Research Group Cardiovascular Diseases, Translational Pathophysiological Research, University of Antwerp, Antwerp, Belgium., Prescott E; Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark., Halle M; Department of Prevention and Sports Medicine, Faculty of Medicine, University Hospital 'Klinikum rechts der Isar', Technical University Munich, Munich, Germany.; Munich Heart Alliance, DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung), partner site Munich, Munich, Germany., Omland T; Department of Cardiology, Division of Medicine, Akershus University Hospital, Lørenskog, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ellingsen Ø; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.; Clinict of Cardiology, St. Olavs University Hospital, Trondheim, Norway., Larsen AI; Department of Cardiology, Stavanger University Hospital, Stavanger, Norway.; Institute of Clinical Science, University of Bergen, Stavanger, Norway.

Publikováno v: ESC heart failure [ESC Heart Fail] 2024 Apr; Vol. 11 (2), pp. 1121-1132. Date of Electronic Publication: 2024 Jan 24.